Related Experiment Video
Updated: May 5, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 29, 2010
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
Dianren Xia1, Dingzhi Wang, Sun-Hee Kim
1Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Abstract:
Although aberrant DNA methylation is considered to be one of the key ways by which tumor-suppressor and DNA-repair genes are silenced during tumor initiation and progression, the mechanisms underlying DNA methylation alterations in cancer remain unclear. Here we show that prostaglandin E(2) (PGE(2)) silences certain tumor-suppressor and DNA-repair genes through DNA methylation to promote tumor growth. These findings uncover a previously unrecognized role for PGE(2) in the promotion of tumor progression.
Insights
Prostaglandin E2 (PGE2) silences tumor-suppressor and DNA-repair genes via DNA methylation, promoting cancer growth. This research reveals a new role for PGE2 in advancing tumor progression.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Aberrant DNA methylation is a key mechanism for silencing tumor-suppressor and DNA-repair genes in cancer.
- The precise mechanisms driving DNA methylation alterations in cancer remain largely unknown.
Purpose of the Study:
- To investigate the role of prostaglandin E2 (PGE2) in regulating DNA methylation of critical genes during cancer development.
- To elucidate the functional impact of PGE2-mediated DNA methylation on tumor progression.
Main Methods:
- Analysis of DNA methylation patterns in cancer cells.
- Assessment of gene expression changes in response to PGE2.
- Correlation of PGE2 levels with gene silencing and tumor growth.
Main Results:
- Prostaglandin E2 (PGE2) was found to induce DNA methylation.
- PGE2-mediated DNA methylation leads to the silencing of specific tumor-suppressor and DNA-repair genes.
- This silencing effect was linked to the promotion of tumor growth.
Conclusions:
- Prostaglandin E2 (PGE2) plays a significant role in cancer progression by silencing crucial genes through DNA methylation.
- These findings identify a novel pathway involving PGE2 in epigenetic regulation during tumorigenesis.
Related Concept Videos
Epigenetic Regulation
Mitogens and the Cell Cycle
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

